Bioinformatic analysis has shown that TRMT6 potentially influences glioma progression by being involved in cell cycle regulation, and the upregulation of PI3K-AKT, TGF-beta, mTORC1, NOTCH and MYC signaling pathways and other vital processes [48]. Here, TRMT6 is linked to central nervous system cancer.